the vet side is a given IMO, and it looks to me that they will keep it for revenue instead of selling it off which im pleased about. *human clinical phase 1/11 begin this DEC 2013. "Testing EBC-46 in a small group of patients (approximately 30) with tumours to primarily evaluate the drug’s safety and safe dose range but also to gain initial information about the drug’s ability to destroy tumours. " *Human clinical phase 11A begin April 2015 "Testing EBC-46 on a larger group of patients (approximately 100) to further examine the drug’s effectiveness to treat tumours"
capital raising currently underway at $0.50 Cents each for a $10million total. "QBIOTICS" is the company for those not in the know. well worth a look, even for interest sack cheers PC
ps. sorry for spelling mistakes in previous post, little bit to much cake and ice-cream sometimes!!
